225 related articles for article (PubMed ID: 1316908)
1. n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells.
Shah S; Lance P; Smith TJ; Berenson CS; Cohen SA; Horvath PJ; Lau JT; Baumann H
J Biol Chem; 1992 May; 267(15):10652-8. PubMed ID: 1316908
[TBL] [Abstract][Full Text] [Related]
2. n-Butyrate mediation of ganglioside expression of human and murine cancer cells demonstrates relative cell specificity.
Berenson CS; Patterson MA; Miqdadi JA; Lance P
Clin Sci (Lond); 1995 Apr; 88(4):491-9. PubMed ID: 7789051
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of glycosyltransferases for N-glycosyl oligosaccharides in fresh human surgical and murine tissues and cultured cell lines.
Li M; Andersen V; Lance P
Clin Sci (Lond); 1995 Oct; 89(4):397-404. PubMed ID: 7493440
[TBL] [Abstract][Full Text] [Related]
4. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
Souady J; Hülsewig M; Distler U; Haier J; Denz A; Pilarsky C; Senninger N; Dreisewerd K; Peter-Katalinic J; Müthing J
Glycobiology; 2011 May; 21(5):584-94. PubMed ID: 21147760
[TBL] [Abstract][Full Text] [Related]
5. n-Butyrate induces plasminogen activator inhibitor type 1 messenger RNA in cultured Hep G2 cells.
Smith TJ; Piscatelli JJ; Andersen V; Wang HS; Lance P
Hepatology; 1996 Apr; 23(4):866-71. PubMed ID: 8666343
[TBL] [Abstract][Full Text] [Related]
6. Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation.
Svensson EC; Soreghan B; Paulson JC
J Biol Chem; 1990 Dec; 265(34):20863-8. PubMed ID: 2249992
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands.
Hanasaki K; Varki A; Stamenkovic I; Bevilacqua MP
J Biol Chem; 1994 Apr; 269(14):10637-43. PubMed ID: 8144653
[TBL] [Abstract][Full Text] [Related]
8. Regulation of expression of beta-galactoside alpha 2,6-sialyltransferase in a rat tumor, Zajdela ascitic hepatoma.
Jain N; Sudhakar C; Das MR
FEBS Lett; 1993 Feb; 317(1-2):147-51. PubMed ID: 8428623
[TBL] [Abstract][Full Text] [Related]
9. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the liver beta-galactoside alpha 2,6-sialyltransferase by glucocorticoids.
Wang XC; Smith TJ; Lau JT
J Biol Chem; 1990 Oct; 265(29):17849-53. PubMed ID: 2211665
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional induction of beta-galactoside alpha-2,6-sialyltransferase in rat fibroblast by dexamethasone.
Vandamme V; Pierce A; Verbert A; Delannoy P
Eur J Biochem; 1993 Jan; 211(1-2):135-40. PubMed ID: 7678804
[TBL] [Abstract][Full Text] [Related]
12. Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor.
Bauvois B; Cacan R; Fournet B; Caen J; Montreuil J; Verbert A
Eur J Biochem; 1982 Jan; 121(3):567-72. PubMed ID: 7035171
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes.
Erikstein BK; Funderud S; Beiske K; Aas-Eng A; De Lange Davies C; Blomhoff HK; Smeland EB
Eur J Immunol; 1992 May; 22(5):1149-55. PubMed ID: 1577059
[TBL] [Abstract][Full Text] [Related]
14. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
[TBL] [Abstract][Full Text] [Related]
15. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro.
Zhu Y; Srivatana U; Ullah A; Gagneja H; Berenson CS; Lance P
Biochim Biophys Acta; 2001 May; 1536(2-3):148-60. PubMed ID: 11406350
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
Dall'Olio F; Chiricolo M; Mariani E; Facchini A
Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific expression of human beta-galactoside alpha 2,6-sialyltransferase transcripts differing in the 5' untranslated region.
Aasheim HC; Aas-Eng DA; Deggerdal A; Blomhoff HK; Funderud S; Smeland EB
Eur J Biochem; 1993 Apr; 213(1):467-75. PubMed ID: 8477718
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis and intracellular transport of alpha-2,6-sialyltransferase in rat hepatoma cells.
Bosshart H; Berger EG
Eur J Biochem; 1992 Sep; 208(2):341-9. PubMed ID: 1521530
[TBL] [Abstract][Full Text] [Related]
19. Photobacterium sp. JT-ISH-224 produces two sialyltransferases, alpha-/beta-galactoside alpha2,3-sialyltransferase and beta-galactoside alpha2,6-sialyltransferase.
Tsukamoto H; Takakura Y; Mine T; Yamamoto T
J Biochem; 2008 Feb; 143(2):187-97. PubMed ID: 17984122
[TBL] [Abstract][Full Text] [Related]
20. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
